On June 3, 2025, SaniMed Founder Jim Wu attended the “Build a Biotech” Forum hosted by JLABS in Houston. The event focused on turning biotech innovations into sustainable businesses. With leaders from JJDC and the global biotech ecosystem, the forum explored strategies for funding, IP, and commercialization. SaniMed continues to foster global collaboration in life sciences innovation.

Jim Wu, founder of SaniMed and Chairman of BioTech, participated in the University of Houston Bauer College of Business SURE Program Impact Forum. He discussed empowering startups and promoting sustainable community development with Dr. Rana Dajani and local leaders, highlighting the role of innovation in strengthening Houston’s economy and fostering social responsibility.

This article highlights key takeaways from the Harvard International Forum on Autism Science and Families, from the perspective of children with autism. At this event, children with autism were no longer seen as peripheral—they became the very center of attention, embraced with understanding, warmth, and respect. No longer were they distant lights; they were radiant, supported stars.

This article summarizes the most compelling insights from the “Harvard International Forum on Autism Science and Family,” focusing specifically on the role of families. It aims to bridge scientific research with real-world family needs, offering practical perspectives and takeaways for families living with autism.

Torskal SAS, a French oncology innovator developing non-ionizing plasmonic PTT for cancers, has partnered with Houston-based SaniMed as its fundraising and strategic business consultant for US and international markets. SaniMed’s expertise in life science investments and commercialization will drive Torskal’s expansion and clinical development. The alliance accelerates breakthrough treatment advancements.